The gut microbiome affects response of treatments in HER2‐negative advanced gastric cancer

Abstract Background Common treatments for metastatic/unresectable HER2‐negative gastric cancer include chemotherapy, immune checkpoint inhibitor monotherapy and chemotherapy plus immune checkpoint inhibitor. However, significant drug resistance exists regardless of the treatment regimen. Methods Pat...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Zihan Han, Siyuan Cheng, Die Dai, Yan Kou, Xiaotian Zhang, Fang Li, Xiaochen Yin, Jingjing Ji, Zhikuan Zhang, Xi Wang, Ning Zhu, Qi Zhang, Yan Tan, Xiaohuan Guo, Lin Shen, Zhi Peng
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wiley 2023-07-01
Edice:	Clinical and Translational Medicine
Témata:	chemotherapy gastric cancer gut microbiome immunotherapy
On-line přístup:	https://doi.org/10.1002/ctm2.1312
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!